Data / Research funding / Migraine
Migraine: 120 NIH awards ($146.5M) to 70 organizations
120 NIH awards ($146.5M) in the NIH spending category Migraine, to 70 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
120 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Site-Directed RNA Editing of Nav1.7 as a Novel Analgesic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,194,636 | September 23, 2021 | August 31, 2027 | ROSENTHAL, JOSHUA J.C. | reporter.nih.gov |
| RELAXaHEAD: A Behavioral Approach to Remote Migraine Management in Primary Care | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $3,954,279 | September 23, 2022 | August 31, 2028 | MINEN, MIA | reporter.nih.gov |
| Mechanisms of Pain and Photophobia in Migraine and Dry Eye | NIH | National Eye Institute | 2022 to 2025 | $3,466,540 | September 30, 2022 | August 31, 2027 | AICHER, SUE A | reporter.nih.gov |
| Mind Body Balance for Pediatric Migraine | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $3,320,406 | June 1, 2020 | May 31, 2026 | POWERS, SCOTT W | reporter.nih.gov |
| Functional peripheral and central vagal neural circuits of interoception inhibiting pain | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,162,890 | January 1, 2022 | October 31, 2025 | KIM, YU SHIN | reporter.nih.gov |
| Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | NIH | National Institute on Drug Abuse | 2024 to 2025 | $2,883,639 | September 30, 2020 | August 31, 2026 | PAPPAS, GEORGE | reporter.nih.gov |
| Personalized Seizure Forecasting: A Precision Medicine Approach | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $2,642,096 | July 1, 2024 | June 30, 2029 | ZAVERI, HITTEN P | reporter.nih.gov |
| Supraspinal Processing of Sensory Aspects of Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,602,000 | December 22, 2000 | August 31, 2027 | COGHILL, ROBERT C | reporter.nih.gov |
| Online TEAM Migraine: Online Techniques and Education Aimed to Manage Migraine | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $2,523,202 | July 1, 2022 | June 30, 2027 | WELLS, REBECCA ERWIN | reporter.nih.gov |
| Brain Circuits of Migraine Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,478,945 | September 30, 2022 | July 31, 2027 | PORRECA, FRANK | reporter.nih.gov |
| Control of Seizure and Migraine Susceptibility by GPR37L1 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,433,005 | July 15, 2021 | June 30, 2027 | HALL, RANDY A. | reporter.nih.gov |
| Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in vivo) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,419,698 | September 30, 2015 | November 30, 2026 | DASILVA, ALEXANDRE | reporter.nih.gov |
| Enhancing Efficacy of Migraine Self-Management in Children with Comorbid Insomnia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,410,913 | April 14, 2020 | March 31, 2026 | PALERMO, TONYA M | reporter.nih.gov |
| Activity-Dependent Influences on Auditory Circuits | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,383,923 | July 1, 2009 | December 31, 2025 | POLLEY, DANIEL B. | reporter.nih.gov |
| Randomized Controlled Trial of Migraine Manager: A Digital Therapeutic Self-Management Tool for Adolescents with Migraine | NIH | National Institute of Nursing Research | 2021 to 2024 | $2,223,497 | August 26, 2020 | May 31, 2026 | HOMMEL, KEVIN | reporter.nih.gov |
| Dissecting Neural Mechanisms Supporting Mind and Body Approaches to Pain Reduction in Youth with Migraine | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $2,200,367 | April 5, 2019 | September 30, 2025 | POWERS, SCOTT W | reporter.nih.gov |
| Sensory Amplifications as Biomarkers of Migraine Progression | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,169,126 | April 15, 2023 | September 30, 2026 | BRENNAN, KEVIN CHRISTOPHER | reporter.nih.gov |
| Pediatric Chronic Headache and COVID-19: Use of Machine Learning and Biobehavioral Analysis to Classify Headache Mechanism and Optimize Treatment Course. | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,140,031 | August 18, 2022 | May 31, 2027 | HOLMES, SCOTT | reporter.nih.gov |
| Development and qualification of Talon microIPG to treat Chronic Migraines | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,108,531 | March 1, 2018 | May 31, 2025 | DULAK, GARY | reporter.nih.gov |
| Isoform- and Sex-Specific Functions of CGRP in Gastrointestinal Motility | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,974,543 | July 15, 2023 | March 31, 2027 | RAO, MEENAKSHI | reporter.nih.gov |
| Mechanisms and Therapeutic Strategies for Post-traumatic Headache | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,934,562 | July 15, 2020 | June 30, 2025 | PORRECA, FRANK | reporter.nih.gov |
| Molecular basis for adenosine A3 receptor agonists in the treatment of migraine | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,903,492 | December 1, 2021 | November 30, 2026 | AKERMAN, SIMON | reporter.nih.gov |
| Elucidating the neural mechanisms of spatial disorientation in vestibular migraine | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $1,851,515 | July 6, 2020 | June 30, 2026 | KHERADMAND, AMIR | reporter.nih.gov |
| Cortical-Meningeal Interactions Underlying Migraine Headache | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,840,774 | December 15, 2020 | November 30, 2026 | LEVY, DAN | reporter.nih.gov |
| Dysfunction of Sodium Homeostasis in Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,826,532 | August 1, 2011 | June 30, 2025 | ARAKAKI, XIANGHONG | reporter.nih.gov |
| Role of Sleep Disruption after mTBI as a Driver of Chronic Post-traumatic Headache | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,798,407 | July 1, 2023 | June 30, 2028 | ILIFF, JEFFREY J | reporter.nih.gov |
| Targeting the Endocannabinoid System for Headache Intervention | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,793,296 | January 1, 2023 | December 31, 2027 | MILNES, TALLY MARIE | reporter.nih.gov |
| Perivascular mechanisms of CGRP-induced migraine symptoms | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,790,788 | June 1, 2011 | March 31, 2025 | RUSSO, ANDREW F | reporter.nih.gov |
| Migraine Onset in Adolescent Girls | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,785,404 | December 15, 2022 | November 30, 2027 | NAHMAN-AVERBUCH, HADAS | reporter.nih.gov |
| Structure, function, and pharmacology of sensory receptors | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,770,256 | September 1, 2024 | August 31, 2032 | LEE, SEOK-YONG | reporter.nih.gov |
| Chiropractic Care for Episodic Migraine | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $1,766,543 | August 1, 2023 | April 30, 2027 | WAYNE, PETER MICHAEL | reporter.nih.gov |
| Response Properties of Meningeal Afferents in Health and Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,730,258 | August 18, 2023 | July 31, 2028 | LEVY, DAN | reporter.nih.gov |
| Narrow Band Green Light Effects on Cortical Excitability and Responsivity in Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,709,272 | August 1, 2023 | July 31, 2028 | BURSTEIN, RAMI | reporter.nih.gov |
| Drug Free Nerve Block Device for the Relief of Pain and Symptoms in Migraines and other Headaches | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,675,670 | April 29, 2020 | August 31, 2025 | POPIELARSKI, STEPHEN | reporter.nih.gov |
| Forecasting Migraine Attacks | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,626,805 | February 1, 2022 | January 31, 2027 | HOULE, TIMOTHY T | reporter.nih.gov |
| Temporal Synthesis of Vestibular and Extra-Vestibular Sensory Signals | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2023 | $1,586,007 | January 1, 2019 | December 31, 2024 | LEWIS, RICHARD F | reporter.nih.gov |
| Structure-based Design of Selective Serotonin Biased Agonists as Chemical Probes for Psychedelic Potential | NIH | National Institute of Mental Health | 2023 to 2025 | $1,564,916 | July 12, 2023 | March 31, 2027 | MCCORVY, JOHN D | reporter.nih.gov |
| Feasibility and Acceptability of Telephone-delivered MBCT for Migraine and Depression (FATE-MD) | NIH | National Center for Complementary & Integrative Health | 2023 to 2024 | $1,561,381 | June 1, 2021 | May 31, 2026 | SHALLCROSS, AMANDA J | reporter.nih.gov |
| How discrete homeostatic signals stabilize synapse function across time | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,547,156 | September 19, 2022 | June 30, 2027 | FRANK, CARL ANDREW | reporter.nih.gov |
| Feasibility and Acceptability of Telephone-delivered MBCT for Migraine and Depression (FATE-MD) | NIH | National Center for Complementary & Integrative Health | 2021 to 2022 | $1,518,866 | June 1, 2021 | September 30, 2022 | SHALLCROSS, AMANDA J | reporter.nih.gov |
| RAMP-altered class B GPCR hormone binding and signaling | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,439,860 | September 26, 2012 | August 31, 2025 | PIOSZAK, AUGEN A | reporter.nih.gov |
| Female-specific role of trigeminal dynorphin in temporomandibular disorder and its comorbidity | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $1,432,055 | August 1, 2022 | July 31, 2027 | TAO, FENG | reporter.nih.gov |
| Safety of Anti-CGRP Migraine Therapeutics in Ischemic Stroke | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,407,797 | June 3, 2023 | May 31, 2028 | AYATA, CENK | reporter.nih.gov |
| The role of delta opioid receptors in trigeminovascular pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,397,603 | March 15, 2023 | January 31, 2028 | PRADHAN, AMYNAH AMIR ALI | reporter.nih.gov |
| Noncanonical glutamate signaling in the origins of the migraine attack | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,380,999 | August 15, 2017 | January 31, 2029 | BRENNAN, KEVIN CHRISTOPHER | reporter.nih.gov |
| Mechanisms of migraine chronification and reversal | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,339,788 | April 1, 2023 | March 31, 2028 | CAO, YUQING | reporter.nih.gov |
| Development of PAC1 receptor antagonists for the treatment of Headache Disorders | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,325,500 | July 1, 2024 | June 30, 2026 | PRADHAN, AMYNAH AMIR ALI | reporter.nih.gov |
| CGRP-CLR mediated regulation of bone healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,219,166 | April 5, 2023 | February 29, 2028 | KALAJZIC, IVO | reporter.nih.gov |
| Migraine Prognosis in Adolescents | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,216,260 | July 1, 2024 | June 30, 2029 | NAHMAN-AVERBUCH, HADAS | reporter.nih.gov |
| Distinct Mechanisms of Cognitive Behavioral Therapy Effects in Youth with Migraine: Insights from Neuroimaging and Quantitative Sensory Testing (The How and Why Youth with Headaches Get Better Study) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,195,673 | April 1, 2018 | March 31, 2025 | POWERS, SCOTT W | reporter.nih.gov |
| Molecular basis for functional S1PR1 antagonists in the treatment of comorbid migraine and temporomandibular disorders | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,190,340 | September 1, 2024 | August 31, 2029 | AKERMAN, SIMON | reporter.nih.gov |
| Molecular, cellular, anatomical and neurobiological investigation of melanopsin-expressing corneal innervation, and its role in pain and photophobia | NIH | National Eye Institute | 2021 to 2024 | $1,165,644 | February 1, 2020 | April 30, 2024 | MATYNIA, ANNA | reporter.nih.gov |
| Predicting Pain Recovery: A Multimodality Machine-learning Approach using Harmonized Electronic Health Record Data | NIH | Office of the Director, National Institutes of Health | 2025 | $1,156,554 | September 15, 2025 | September 14, 2026 | CHONG, CATHERINE DANIELA | reporter.nih.gov |
| Flicker photophobia as an experience of inefficient coding | NIH | National Eye Institute | 2024 to 2025 | $1,119,788 | June 1, 2024 | March 31, 2028 | AGUIRRE, GEOFFREY KARL | reporter.nih.gov |
| Understanding multisensory hypersensitivity in chronic pain states | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,110,075 | January 15, 2017 | November 30, 2024 | HEINRICHER, MARY MAGDALEN | reporter.nih.gov |
| Astrocytic mechanisms in a new genetic model of migraine | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,014,202 | July 1, 2018 | April 30, 2024 | BRENNAN, KEVIN CHRISTOPHER | reporter.nih.gov |
| CGRP's effect on hearing and balance in a mouse model of migraine | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2022 | $986,831 | July 1, 2018 | June 30, 2025 | LUEBKE, ANNE E | reporter.nih.gov |
| Development of Mi-Helper: A Thermodynamic Neuromodulation Device for Migraine Relief | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $983,042 | September 17, 2025 | August 31, 2027 | SCHAEFER, STEVEN EDWARD | reporter.nih.gov |
| Meningeal prolactin signaling and female-selective migraine mechanisms | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $951,182 | August 15, 2018 | June 30, 2024 | DUSSOR, GREGORY O | reporter.nih.gov |
| The role of neuro-immune interactions in PACAP induced migraine | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $949,262 | January 10, 2024 | December 31, 2028 | GREEN, DUSTIN PEPPER | reporter.nih.gov |
| Regulation of headache pain responses by the Trigeminal ganglion clock | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $936,775 | April 17, 2024 | March 31, 2029 | YOO, SEUNG-HEE | reporter.nih.gov |
| Transnasal Cooling to Reduce Pain from Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $915,105 | September 30, 2020 | February 28, 2023 | LANE, BENJAMIN R | reporter.nih.gov |
| Sex Differences in the Role of Gonadal Hormones and the Hypothalamus in Migraine with Aura. | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $885,290 | July 1, 2022 | June 30, 2027 | HARRIOTT, ANDREA M | reporter.nih.gov |
| Measuring Migraine Attack Risks | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $879,375 | September 15, 2019 | June 30, 2026 | TURNER, DANA | reporter.nih.gov |
| Neural Pathways of Light Aversion in a Rodent Model of Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $858,438 | September 30, 2020 | August 31, 2025 | KAISER, ERIC ALAN | reporter.nih.gov |
| Precision TMS with integrated visualization and analysis of real-time E-field and EEG source imaging | NIH | National Institute of Mental Health | 2025 | $830,409 | March 1, 2025 | January 31, 2030 | NING, LIPENG | reporter.nih.gov |
| Trigeminovascular sensitization in post-traumatic headache: electrophysiologic and blood biomarkers in youth | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $828,731 | July 1, 2022 | May 31, 2027 | PATTERSON GENTILE, CARLYN ANNE | reporter.nih.gov |
| Central vs. Peripheral Mechanisms of Headache: Cortex, Thalamus, Dorsal Horn | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $796,637 | April 5, 2024 | March 31, 2029 | STRASSMAN, ANDREW MARK | reporter.nih.gov |
| Photophobia and Pupillary Autonomic Dysfunction as Biomarkers of Post-Traumatic Headache | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $795,587 | April 15, 2020 | September 30, 2025 | CORTEZ, MELISSA | reporter.nih.gov |
| Molecular and Cellular signaling mechanisms of TRPV4 in non-neuronal cells: a pathophysiological relevance for migraine pain. | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $767,559 | December 1, 2021 | November 30, 2026 | MOORE, CARLENE D | reporter.nih.gov |
| Pathophysiology of Occipital Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $765,626 | December 1, 2017 | November 30, 2023 | NOSEDA, RODRIGO | reporter.nih.gov |
| Feasibility Trial of Home-Based Immersive Neurofeedback Self-Regulation Training (INSeRT) for the Preventive Treatment of Pediatric Migraine | NIH | National Center for Complementary & Integrative Health | 2025 | $753,142 | September 22, 2025 | August 31, 2028 | CONNELLY, MARK ANDREW | reporter.nih.gov |
| The gut brain axis: microbial impact on neural function | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $732,812 | June 1, 2018 | February 28, 2023 | ALKEMA, MARK | reporter.nih.gov |
| Feasibility, Acceptability, and Pilot Testing of a Behavioral Intervention for Chronic Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $721,062 | September 30, 2021 | March 29, 2024 | WOLDEAMANUEL, YOHANNES WOUBISHET | reporter.nih.gov |
| Long acting and peripherally restricted kappa-opioid receptor agonists for acute migraine treatment | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $698,722 | September 15, 2021 | February 28, 2023 | RIVIERE, PIERRE | reporter.nih.gov |
| Prolactin monoclonal antibodies (PRL-mAbs) for the treatment of female-predominant pain syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $695,919 | July 1, 2021 | June 30, 2023 | RIVIERE, PIERRE | reporter.nih.gov |
| Efficacy of a Single-Session Telehealth-Based Behavioral Intervention for Chronic Migraines | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $693,385 | December 15, 2021 | November 30, 2026 | STURGEON, JOHN ANDREW | reporter.nih.gov |
| Regulation of Trigeminal Nociception by TRESK Channels | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $674,947 | April 1, 2018 | March 31, 2024 | CAO, YUQING | reporter.nih.gov |
| MECHANISMS OF CSD-EVOKED PERSISTENT ACTIVATION OF MENINGEAL NOCICEPTORS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $582,262 | July 15, 2013 | May 31, 2024 | LEVY, DAN | reporter.nih.gov |
| Adenosine Modulation of the Bi-Directional Relationship between Sleep and Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $574,830 | March 15, 2024 | February 28, 2029 | NWAOBI, SINIFUNANYA ELVEE | reporter.nih.gov |
| Strategic Reprogramming of the Ergot Alkaloid Pathway | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $542,386 | April 1, 2015 | August 31, 2025 | PANACCIONE, DANIEL G. | reporter.nih.gov |
| Cocoa Flavanols for Migraine: A Pilot Study | NIH | National Center for Complementary & Integrative Health | 2024 | $530,030 | September 1, 2024 | May 31, 2027 | RIST, PAMELA M. | reporter.nih.gov |
| Development of a Drug Candidate for the Treatment of Agitation in Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $495,699 | September 20, 2025 | September 19, 2027 | GRESACK, JODI ELLEN | reporter.nih.gov |
| Meningeal Nociceptor-Immune Signaling in Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $491,660 | September 1, 2022 | August 31, 2025 | LEVY, DAN | reporter.nih.gov |
| Feasibility, Acceptability, and Pilot Testing of a Behavioral Intervention for Chronic Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $480,708 | September 30, 2021 | August 31, 2026 | WOLDEAMANUEL, YOHANNES WOUBISHET | reporter.nih.gov |
| The pathophysiology of morning migraine | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $475,475 | July 1, 2025 | June 30, 2027 | MELO CARRILLO, AGUSTIN | reporter.nih.gov |
| RgIA5474 as a Novel α9α10 Nicotinic Acetylcholine Receptor Antagonist to Treat Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $472,592 | August 1, 2025 | July 31, 2028 | XIE, YANHUA | reporter.nih.gov |
| A novel platform for the discovery and characterization of migraine therapies | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $455,371 | September 1, 2024 | August 31, 2025 | CHARLES, ANDREW C | reporter.nih.gov |
| Linking trigeminal and visual sensitivity in migraine | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $446,875 | September 19, 2022 | August 31, 2025 | AGUIRRE, GEOFFREY KARL | reporter.nih.gov |
| Progesterone receptors and migraine chronification | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $444,125 | July 18, 2025 | June 30, 2027 | JOSHI, SUCHITRA | reporter.nih.gov |
| Grape Seed Extract Modulation of Peripheral and Central Nervous System Neuron-Glia Interactions | NIH | National Center for Complementary & Integrative Health | 2024 | $427,500 | April 1, 2024 | March 31, 2027 | DURHAM, PAUL L | reporter.nih.gov |
| Noninvasive Vagus Nerve Stimulation for Treatment of Brain Injury (nVNS-TBI) in Rats | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $419,375 | September 23, 2022 | August 31, 2025 | DIVANI, AFSHIN ANDRE | reporter.nih.gov |
| The involvement of GPR37L1 on a chronic migraine-like state | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $419,375 | July 10, 2024 | June 30, 2026 | CIPPITELLI, ANDREA | reporter.nih.gov |
| Non-invasive lighting treatment as a novel therapeutic for age-related cognitive decline | NIH | National Institute on Aging | 2023 to 2024 | $416,149 | June 1, 2023 | March 31, 2026 | KRIEGSFELD, LANCE J | reporter.nih.gov |
| Predicting Migraine Attack Onset with Real-Time Individualized Autonomic Patterns | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $415,249 | August 7, 2025 | July 31, 2027 | DASILVA, ALEXANDRE | reporter.nih.gov |
| Progressive Muscle Relaxation for Chronic Pain in an Acute Care Setting | NIH | National Center for Complementary & Integrative Health | 2021 to 2022 | $401,295 | January 12, 2018 | September 30, 2023 | MINEN, MIA | reporter.nih.gov |
| Investigating the aggregation of amyloid β during metabolic stress using multiscale modeling | NIH | National Institute on Aging | 2024 to 2025 | $393,731 | September 1, 2024 | December 31, 2026 | ULLAH, GHANIM | reporter.nih.gov |
| RAMP-altered class B GPCR hormone binding and signaling | NIH | National Institute of General Medical Sciences | 2025 | $389,310 | September 1, 2025 | July 31, 2030 | PIOSZAK, AUGEN A | reporter.nih.gov |
| Occipital Nerve Blocks for Acute Treatment of Pediatric Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $376,056 | July 1, 2018 | June 30, 2023 | SZPERKA, CHRISTINA LYNCH | reporter.nih.gov |
| Characterization and Digital Phenotyping of Migraine and Affective Disorders during Hormonal Fluctuations across the Life Course | NIH | National Institute of Mental Health | 2024 to 2025 | $370,440 | September 5, 2024 | August 31, 2028 | CROWE, HOLLY MICHELLE | reporter.nih.gov |
| Developing multitarget enzyme inhibitors as safe and effective anti-migraine treatments | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $357,093 | August 1, 2023 | June 30, 2027 | KANDASAMY, RAM | reporter.nih.gov |
| Development of an intranasal, direct to nerve treatment for headache disorders | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $336,946 | August 19, 2022 | July 31, 2024 | BECKWITH, JONATHAN G | reporter.nih.gov |
| The role of chronic migraine as an early biomarker of Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $317,000 | September 1, 2025 | August 31, 2027 | FISCHER, KATHRYN | reporter.nih.gov |
| Protease-activated-receptor-2 antagonists for treatment of migraine pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $310,351 | January 15, 2023 | October 31, 2024 | DEFEA, KATHRYN ANNE | reporter.nih.gov |
| Feasibility Trial of a Remotely-Delivered Mindfulness-Based Intervention for Adolescents with Migraine | NIH | National Center for Complementary & Integrative Health | 2025 | $198,129 | August 18, 2025 | July 31, 2030 | CLEMENTI, MICHELLE ANDREA | reporter.nih.gov |
| Effects of ICP elevation on NeuN Negative Membrane Disrupted Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $172,345 | July 1, 2022 | August 31, 2028 | HERNANDEZ, MARTINA LAURA | reporter.nih.gov |
| Investigating neural mechanisms of interoceptive awareness in migraine | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $164,000 | June 1, 2024 | May 31, 2026 | DATKO, MICHAEL | reporter.nih.gov |
| Civamide Nasal Spray for the Treatment of Dry Eye | NIH | National Eye Institute | 2022 | $160,284 | February 1, 2022 | August 11, 2022 | PHILLIPS, SCOTT | reporter.nih.gov |
| The role of meningeal immune cells in the efficacy of CGRP-based migraine therapies | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $146,206 | January 1, 2023 | December 31, 2025 | ADI, TALIA | reporter.nih.gov |
| Electrical connectomics: an innovative approach for dissecting brain mechanisms underlying behavioral states | NIH | National Institute of Mental Health | 2023 | $113,733 | September 7, 2020 | May 31, 2025 | HULTMAN, RAINBO | reporter.nih.gov |
| The Role of Parabrachial CGRP Neurons in Opioid Reinforcement | NIH | National Institute on Drug Abuse | 2024 to 2025 | $108,512 | May 1, 2024 | April 30, 2028 | BYSTROM, LAUREN L | reporter.nih.gov |
| The impact of hallucinogens on active sampling and the olfactory bulb | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2024 | $94,376 | April 1, 2023 | March 31, 2025 | WELCH, AMANDA COLETTE | reporter.nih.gov |
| Effects of ICP elevation on NeuN Negative Membrane Disrupted Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $82,446 | July 1, 2022 | August 31, 2023 | HERNANDEZ, MARTINA LAURA | reporter.nih.gov |
| Migraine, Depressive Symptoms, and Maternal Quality of Life in the Postpartum Period: The Role of Comorbidity, Disengagement, and Social and Economic Disadvantage | NIH | National Institute of Nursing Research | 2021 to 2025 | $79,622 | September 1, 2021 | January 31, 2026 | MATTHEWS, ANNA ROTHFUSS | reporter.nih.gov |
| A genetic approach to identify the common mechanisms of vascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 | $68,349 | September 1, 2019 | August 6, 2022 | GUPTA, RAJAT M | reporter.nih.gov |
| Efficacy of a Single-Session Telehealth-Based Behavioral Intervention for Chronic Migraines | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $62,615 | December 15, 2021 | July 15, 2022 | STURGEON, JOHN ANDREW | reporter.nih.gov |
| Understanding the Impact of CACNA1A/unc-2 Mutations on Presynaptic Structure and Function in C. Elegans | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $49,538 | February 15, 2025 | February 14, 2027 | KRAWCHUK, MICHAEL B | reporter.nih.gov |
| Molecular and Functional Mechanisms Underlying Cortical Activity in CACNA1A Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $49,538 | July 1, 2025 | November 30, 2027 | SARKISSIAN, ARVIN ABRAMOVICH | reporter.nih.gov |
| Investigating the Cortical Action of Psilocybin in Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $39,382 | May 9, 2025 | December 31, 2025 | ROGERS, SOPHIE | reporter.nih.gov |
| Pneumonia-induced microglial activation causes blood-brain barrier breakdown, astrocyte activation, and tau pathology | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $33,975 | September 1, 2024 | September 2, 2025 | CHANEY, SAMANTHA DAWN | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 66 | $36,349,970 | 0 | $0 |
| 2024 | 68 | $32,734,420 | 0 | $0 |
| 2023 | 57 | $26,302,633 | 0 | $0 |
| 2022 | 60 | $27,363,573 | 0 | $0 |
| 2021 | 36 | $23,699,646 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.